NCT02566746View on ClinicalTrials.gov

Contribution of Percutaneous Endoscopic Caecostomie in the Management of Severe Constipation Refractory to Medical Treatment

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

June 20, 2016

Primary Completion Date

June 23, 2022

Study Completion Date

June 23, 2022

Conditions
Constipation
Interventions
DEVICE

Chait Trapdoor caecostomie catheter

implantation of the Chait Trapdoor caecostomie catheter

DRUG

continuation of optimal medical therapy

continuation of treatment with laxative and / or suppositories and / or enemas retrograde At 12 months : implantation of the Chait Trapdoor caecostomie catheter

Trial Locations (3)

44093

CHU de Nantes, Nantes

56270

CMRRF de Kerpape, Ploemeur

Unknown

CHU de Rouen, Rouen

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT02566746 - Contribution of Percutaneous Endoscopic Caecostomie in the Management of Severe Constipation Refractory to Medical Treatment | Biotech Hunter | Biotech Hunter